GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korean Drug Co Ltd (XKRX:014570) » Definitions » EV-to-Revenue

Korean Drug Co (XKRX:014570) EV-to-Revenue : 0.40 (As of Jun. 04, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Korean Drug Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Korean Drug Co's enterprise value is ₩26,993 Mil. Korean Drug Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₩66,774 Mil. Therefore, Korean Drug Co's EV-to-Revenue for today is 0.40.

The historical rank and industry rank for Korean Drug Co's EV-to-Revenue or its related term are showing as below:

XKRX:014570' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.35   Med: 1.2   Max: 2.78
Current: 0.4

During the past 13 years, the highest EV-to-Revenue of Korean Drug Co was 2.78. The lowest was 0.35. And the median was 1.20.

XKRX:014570's EV-to-Revenue is ranked better than
93.63% of 973 companies
in the Drug Manufacturers industry
Industry Median: 2.43 vs XKRX:014570: 0.40

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-04), Korean Drug Co's stock price is ₩4870.00. Korean Drug Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩6,209.18. Therefore, Korean Drug Co's PS Ratio for today is 0.78.


Korean Drug Co EV-to-Revenue Historical Data

The historical data trend for Korean Drug Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korean Drug Co EV-to-Revenue Chart

Korean Drug Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.35 0.92 0.73 0.75 0.42

Korean Drug Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.54 0.46 0.42 0.34

Competitive Comparison of Korean Drug Co's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Korean Drug Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Korean Drug Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Korean Drug Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Korean Drug Co's EV-to-Revenue falls into.


;
;

Korean Drug Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Korean Drug Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=26993.441/66774.441
=0.40

Korean Drug Co's current Enterprise Value is ₩26,993 Mil.
Korean Drug Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩66,774 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Korean Drug Co  (XKRX:014570) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Korean Drug Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4870.00/6209.183
=0.78

Korean Drug Co's share price for today is ₩4870.00.
Korean Drug Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,209.18.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Korean Drug Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Korean Drug Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Korean Drug Co Business Description

Traded in Other Exchanges
N/A
Address
486 Sukwang-ri Sindun-myun, Icheon, Gyeonggi, KOR, 457-840
Korean Drug Co Ltd is engaged in manufacturing and marketing of pharmaceutical products in South Korea. Its products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food.

Korean Drug Co Headlines

No Headlines